Schedule 13G ownership disclosure

REGULUS THERAPEUTICS INC

Security class unavailable · CUSIP: 75915K309

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
895,200
Percent of class
1.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001389932-24-000022
Form type
SC 13G/A
Filer
DAFNA Capital Management LLC
CIK
CIK 1389933
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub